GlassScriptPhysician profile
Omar E Elbanhawy
NPI 1780994533
$19,761.23
in general payments reported to CMS, 2019-2025
8 companies · $512 in 2025
The $512 reported for 2025 was more than what 82% of Periodontics providers received nationally (typical 2025 total: $111).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,065 · 2020: $1,113 · 2021: $431 · 2022: $6,936 · 2023: $4,027 · 2024: $1,676 · 2025: $512.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,988 · Food and Beverage: $1,868 · Education: $281 · Gift: $78.46.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,988.05 |
| Food and Beverage | $1,867.98 |
| Education | $281.25 |
| Gift | $78.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Straumann USA LLC | $8,702.89 | 2019-2025 | |
| Zimvie INC. | $5,995.06 | 2022-2025 | |
| Zimmer Biomet Holdings, INC. | $4,908.16 | 2019-2021 | |
| Ultradent Products INC | $59.88 | 2022 | |
| 3shape INC | $38.65 | 2023 | Trios 5 |
| Midmark Corporation | $21.11 | 2022 | |
| Orapharma, A Division of Bausch Health US, LLC | $20.39 | 2025 | Arestin |
| Southern Implants North America INC | $15.09 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Omar Elbanhawy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.